Article Information
History
- January 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jungeui Hong1,2,
- Zachary Kohutek5,
- Haochen Zhang1,3,
- Elias-Ramzey Karnoub1,2,
- Rajya Kappagantula1,2,
- Laura D. Wood6 and
- Christine Iacobuzio-Donahue1,2,4,*
- 1David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA
- 2Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, York, NY 10065 USA
- 3Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA
- 4Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA
- 5Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232 USA
- 6Division of Gastrointestinal Pathology, Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21287 USA
- ↵*Correspondence: iacobuzc{at}mskcc.org
Posted January 30, 2024.
Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer
